Dr. Lal Path Labs Ltd consolidated Q1FY22 PAT zooms to Rs. 131.2 crores

Dr. Lal PathLabs Ltd has reported financial results for the period ended June 30, 2021.

Financial Results (Q1 FY 2021-22) - QoQ Comparison

The company has reported total income of Rs.620.7 crores during the period ended June 30, 2021 as compared to Rs.444.5 crores during the period ended March 31, 2021.

The company has posted net profit / (loss) of Rs.131.2 crores for the period ended June 30, 2021 as against net profit / (loss) of Rs.83.4 crores for the period ended March 31, 2021.

The company has reported EPS of Rs.15.84 for the period ended June 30, 2021 as compared to Rs.10.07 for the period ended March 31, 2021.

Financials	Q1 FY2021-22	Q4 FY20-21	% Change
Total Income	₹ 620.7 crs	₹ 444.5 crs	39.64%
Net Profit	₹ 131.2 crs	₹ 83.4 crs	57.31%
EPS	₹ 15.84	₹ 10.07	57.3%

Financial Results (Q1 FY 2021-22) - YoY Comparison

The company has reported total income of Rs.620.7 crores during the period ended June 30, 2021 as compared to Rs.277.4 crores during the period ended June 30, 2020.

The company has posted net profit / (loss) of Rs.131.2 crores for the period ended June 30, 2021 as against net profit / (loss) of Rs.28.4 crores for the period ended June 30, 2020.

The company has reported EPS of Rs.15.84 for the period ended June 30, 2021 as compared to Rs.3.44 for the period ended June 30, 2020.

Financials	Q1 FY2021-22	Q1 FY2020-21	% Change
Total Income	₹ 620.7 crs	₹ 277.4 crs	123.76%
Net Profit	₹ 131.2 crs	₹ 28.4 crs	361.97%
EPS	₹ 15.84	₹ 3.44	360.47%

Shares of Dr. Lal PathLabs Ltd was last trading in BSE at Rs. 3750 as compared to the previous close of Rs. 3622.3. The total number of shares traded during the day was 15626 in over 2868 trades.

The stock hit an intraday high of Rs. 3750 and intraday low of 3605.05. The net turnover during the day was Rs. 57794294.

Source : Equity Bulls

Keywords